KTC
BMY icon

Kentucky Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Kentucky Trust Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713K Buy
12,378
+906
+8% +$52K 0.34% 67
2026
Q1 		$696K Buy
11,472
+1,230
+12% +$71.7K 0.36% 64
2025
Q4 		$552K Buy
10,242
+1,767
+21% +$85K 0.29% 73
2025
Q3 		$382K Buy
8,475
+970
+13% +$45.3K 0.21% 85
2025
Q2 		$347K Buy
7,505
+200
+3% +$9.82K 0.2% 89
2025
Q1 		$446K Buy
7,305
+430
+6% +$25.1K 0.26% 80
2024
Q4 		$389K Buy
+6,875
New +$384K 0.23% 86

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kentucky Trust Company's BMY Position: Q2 2026 in Review

Kentucky Trust Company increased its Bristol-Myers Squibb (BMY) stake by 7.9% in Q2 2026, buying an estimated $52K and bringing the position to 12,378 shares worth $713K. The position accounts for 0.34% of the portfolio, ranked #67.

Kentucky Trust Company first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Kentucky Trust Company held 12,378 shares of Bristol-Myers Squibb worth $713K as of Q2 2026.
  • Kentucky Trust Company bought 906 Bristol-Myers Squibb shares in Q2 2026, an estimated $52K.
  • Bristol-Myers Squibb made up 0.34% of Kentucky Trust Company's portfolio in Q2 2026, its #67 holding.
  • Kentucky Trust Company first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Kentucky Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.